Literature DB >> 33100912

Normal lung tissue complication probability in MR-Linac and conventional radiotherapy.

Somayeh Gholami1,2, Francesco Longo3, Sara Shahzadeh4, Hassan Ali Nedaie1,2, Ryan Sharp5, Ali S Meigooni6.   

Abstract

PURPOSE: To study normal lung tissue (NLT) complications in magnetic resonance (MR) image based linac and conventional radiotherapy (RT) techniques.
MATERIALS AND METHODS: The Geant4 toolkit was used to simulate a 6 MV photon beam. A homogenous magnetic field of 1.5 Tesla (T) was applied in both perpendicular and parallel directions relative to the radiation beam.Analysis of the NLT complications was assessed according to the normal lung tissue complication probability (NTCP), the mean lung dose (MLD), and percentage of the lung volume receiving doses greater than 20 Gy (V20), using a sample set of CT images generated from a commercially available 4D-XCAT digital phantom.
RESULTS: The results show that the MLD and V20 were lower for MR-linac RT. The largest reduction of MLD and V20 for MR-linac RT configurations were 5 Gy and 29.3%, respectively.
CONCLUSION: MR-linac RT may result in lower NLT complications when compared to conventional RT.
© 2020 Greater Poland Cancer Centre. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Geant4 toolkit; MR-linac; Normal lung tissue complications; XCAT digital phantom

Year:  2020        PMID: 33100912      PMCID: PMC7569234          DOI: 10.1016/j.rpor.2020.09.002

Source DB:  PubMed          Journal:  Rep Pract Oncol Radiother        ISSN: 1507-1367


  32 in total

1.  Lung dosimetry in a linac-MRI radiotherapy unit with a longitudinal magnetic field.

Authors:  C Kirkby; B Murray; S Rathee; B G Fallone
Journal:  Med Phys       Date:  2010-09       Impact factor: 4.071

2.  Adaptation and applications of a realistic digital phantom based on patient lung tumor trajectories.

Authors:  Pankaj Mishra; Sara St James; W Paul Segars; Ross I Berbeco; John H Lewis
Journal:  Phys Med Biol       Date:  2012-06-07       Impact factor: 3.609

3.  A free program for calculating EUD-based NTCP and TCP in external beam radiotherapy.

Authors:  Hiram A Gay; Andrzej Niemierko
Journal:  Phys Med       Date:  2007-09-07       Impact factor: 2.685

4.  Magnetic confinement of electron and photon radiotherapy dose: a Monte Carlo simulation with a nonuniform longitudinal magnetic field.

Authors:  Yu Chen; Alex F Bielajew; Dale W Litzenberg; Jean M Moran; Frederick D Becchetti
Journal:  Med Phys       Date:  2005-12       Impact factor: 4.071

5.  A comparative planning study for lung SABR between tri-Co-60 magnetic resonance image guided radiation therapy system and volumetric modulated arc therapy.

Authors:  Jong Min Park; So-Yeon Park; Hak Jae Kim; Hong-Gyun Wu; Joel Carlson; Jung-In Kim
Journal:  Radiother Oncol       Date:  2016-07-08       Impact factor: 6.280

6.  Biological effects and equivalent doses in radiotherapy: A software solution.

Authors:  Cyril Voyant; Daniel Julian; Rudy Roustit; Katia Biffi; Céline Lantieri
Journal:  Rep Pract Oncol Radiother       Date:  2013-09-29

7.  The effect of strong longitudinal magnetic fields on dose deposition from electron and photon beams.

Authors:  A F Bielajew
Journal:  Med Phys       Date:  1993 Jul-Aug       Impact factor: 4.071

8.  Patient dosimetry for hybrid MRI-radiotherapy systems.

Authors:  C Kirkby; T Stanescu; S Rathee; M Carlone; B Murray; B G Fallone
Journal:  Med Phys       Date:  2008-03       Impact factor: 4.071

9.  Effect of normal lung definition on lung dosimetry and lung toxicity prediction in radiation therapy treatment planning.

Authors:  Weili Wang; Yaping Xu; Matthew Schipper; Martha M Matuszak; Timothy Ritter; Yue Cao; Randall K Ten Haken; Feng-Ming Spring Kong
Journal:  Int J Radiat Oncol Biol Phys       Date:  2013-08-01       Impact factor: 7.038

10.  Lung stereotactic body radiotherapy with an MR-linac - Quantifying the impact of the magnetic field and real-time tumor tracking.

Authors:  Martin J Menten; Martin F Fast; Simeon Nill; Cornelis P Kamerling; Fiona McDonald; Uwe Oelfke
Journal:  Radiother Oncol       Date:  2016-05-08       Impact factor: 6.280

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.